Growth hormone therapy before and after pediatric renal transplant Journal Articles

abstract

• Abstract:  Children undergoing successful renal transplantation anticipate optimal growth and development. The use of rhGH pre‐ and post‐Tx has been evaluated and supported by randomized control trials. Several strategies are required to maximize the potential benefit of this treatment in the renal population including provision of adequate nutrition intake, following bone parameters with appropriate interventions, and strategies to reduce steroid therapy including utilization of alternate day steroid treatment. Studies are required to further assess the impact of rhGH on renal allograft function, rejection risk, and allograft ultrastructural changes.

authors

• Acott, Philip D
• Pernica, Jeffrey

status

• published 

publication date

• December 2003

has subject area

• 1114 Paediatrics and Reproductive Medicine (FoR)
• Child (MeSH)
• Child Development (MeSH)
• Human Growth Hormone (MeSH)
• Humans (MeSH)
• Kidney Transplantation (MeSH)
• Pediatrics (MeSH)
• Randomized Controlled Trials as Topic (MeSH)
• Recombinant Proteins (MeSH)
• Surgery (Science Metrix)

published in

• Pediatric Transplantation  Journal

keywords

• Child
• Child Development
• Human Growth Hormone
• Humans
• Kidney Transplantation
• Pediatrics
• Randomized Controlled Trials as Topic
• Recombinant Proteins

Digital Object Identifier (DOI)

• 10.1046/j.1397-3142.2003.00108.x

PubMed ID

• 14870889

start page

• 426

end page

• 440

volume

• 7

issue

• 6